Position in IRWD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$110,925
-$5,585 QoQ
Shares Held
26,348
-20.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 34 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Krilogy Financial LLC holds $3,083,818 across 8 Drug Manufacturers - Specialty & Generic names. IRWD ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,884 | $1,160,229 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,510 | $818,163 | |
| 3 | VTRS |
Viatris Inc
|
31,126 | $494,280 | |
| 4 | ZTS |
Zoetis Inc.
|
3,606 | $259,127 | |
| 5 | PRGO |
PERRIGO Co plc
|
11,976 | $124,430 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
This page
|
26,348 | $110,925 | |
| 7 | EOLS |
Evolus, Inc.
|
11,587 | $80,413 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
11,472 | $36,251 |
All Filings in IRWD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,925 | 26,348 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $116,510 | 33,194 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $101,851 | 30,223 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $39,572 | 30,208 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||